Companies › Johnson & Johnson · Global Markets & Policy
Johnson & Johnson
- NYSE: JNJ
US healthcare company making prescription drugs and medical devices.
Johnson & Johnson quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $67.8M, purchases $0. All Johnson & Johnson insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Timothy Schmid EVP, WW Chair, MedTech | Open-market sale | 11,070 | $274.74 | $3.0M | Form 4 ↗ |
| Sep 2, 2026 | Timothy Schmid EVP, WW Chair, MedTech | Open-market sale | 22,527 | $274.74 | $6.2M | Form 4 ↗ |
| Aug 17, 2026 | Jennifer L Taubert EVP, WWC. Innovative Medicine | Open-market sale | 15,000 | $263.36 | $4.0M | Form 4 ↗ |
| Aug 13, 2026 | Joaquin Duato CEO and Chairman of the Board, Director | Open-market sale | 20,976 | $262.00 | $5.5M | Form 4 ↗ |
| Aug 13, 2026 | Joaquin Duato CEO and Chairman of the Board, Director | Open-market sale | 102,315 | $261.00 | $26.7M | Form 4 ↗ |
Key financials
| Metric | FY to Jan 2023 | FY to Dec 2023 | FY to Dec 2024 | FY to Dec 2025 |
|---|---|---|---|---|
| Revenue | $80.0B | $85.2B | $88.8B | $94.2B |
| Net income | $17.9B | $35.2B | $14.1B | $26.8B |
| Diluted EPS | $6.73 | $13.72 | $5.79 | $11.03 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-10-13 · 8-K — Results of operations
- 2026-08-04 · 8-K — Director or officer change
- 2026-07-29 · 8-K — Regulation FD disclosure
- 2026-07-28 · 8-K — Regulation FD disclosure
- 2026-07-23 · 10-Q
- 2026-07-15 · 8-K — Results of operations
- 2026-04-28 · 8-K — Shareholder vote results
- 2026-04-22 · 10-Q
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.